Plain-English translation of NCT07550699 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the ABLE Exoskeleton with Functional Electrical Stimulation (ABLE FES)—a robotic walking device combined with gentle electrical stimulation of the leg muscles. The study aims to find out whether this combination is safe and can help people with mobility challenges from spinal cord injury, stroke, or multiple sclerosis walk better and farther.
Currently, people recovering from these neurological conditions often struggle to regain walking ability. This trial explores whether combining robotic support with electrical muscle stimulation—a technique that uses gentle electrical pulses to activate muscles—might be a better way to help patients retrain their legs to walk.
You likely qualify if…
You likely don't qualify if…
You would attend 8 training sessions over 4 to 5 weeks, coming twice per week. Each 60-minute session involves putting on the exoskeleton (called donning), walking practice with the device and electrical stimulation, and brief assessments. Before your first session, you'll have a baseline visit, and after your last session you'll have final assessments and a follow-up visit two weeks later.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Austria